Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: IQE CEO raises stake
(Sharecast News) - IQE revealed on Friday that chief executive Americo Lemos had acquired 1.36m ordinary shares in the AIM-listed compound semiconductor wafer products supplier. Lemos, who joined IQE in January 2022, purchased the shares on Thursday at an average price of 17.15p each, for a total value of £234,442.55.
Following the transaction, Lemos has a beneficial interest in 9.83m ordinary IQE shares, representing approximately 1.02% of the company's issued share capital.
As of 1615 GMT, IQE shares were down 1.11% at 17.84p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Allergy Therapeutics (AGY) Director name: Shen ,Zheqing Amount purchased: 247,935,056 @ 1.00p Value: �2,479,350.50
Iqe (IQE) Director name: Lemos,Americo Amount purchased: 1,367,012 @ 17.15p Value: �234,442.55
Octopus Aim Vct 2 (OSEC) Director name: Richard Mullins,Keith Amount purchased: 108,366 @ 49.60p Value: �53,749.54
Asia Dragon Trust (DGN) Director name: Dobbs,Matthew Amount purchased: 15,000 @ 334.00p Value: �50,100.00
Afentra (AET) Director name: Wilson,Gavin Amount purchased: 150,000 @ 29.99p Value: �44,985.00
Iwg (IWG) Director name: Pauly,Francois Amount purchased: 25,000 @ 139.60p Value: �34,900.00
Arix Bioscience (ARIX) Director name: Smith,Andrew Amount purchased: 25,000 @ 113.00p Value: �28,250.00
Octopus Aim Vct (OOA) Director name: Boteler,Andrew Norman Amount purchased: 16,068 @ 66.90p Value: �10,749.49
Octopus Aim Vct (OOA) Director name: Ransome,Neal Amount purchased: 16,068 @ 66.90p Value: �10,749.49
Norman Broadbent (NBB) Director name: Kempster,Jon Amount purchased: 163,070 @ 6.13p Value: �9,988.04
Cornerstone Fs (CSFS) Director name: Hickman,James Amount purchased: 74,649 @ 13.38p Value: �9,988.04
Silver Bullet Data Services Group (SBDS) Director name: Sharrocks,Nigel Amount purchased: 9,223 @ 80.00p Value: �7,378.40
Silver Bullet Data Services Group (SBDS) Director name: Clarke,Stephen Amount purchased: 9,222 @ 80.00p Value: �7,377.60
Big Technologies (BIG) Director name: Morris,Daren John Amount purchased: 3,000 @ 177.00p Value: �5,310.00
Investment Company (INV) Director name: Perrin,Martin Henry Withers Amount purchased: 1,609 @ 287.00p Value: �4,617.83
Rentokil Initial (RTO) Director name: Mistry,Sarosh Amount purchased: 1,000 @ $5.43 Value: $4,476.79
Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 15,825 @ 27.05p Value: �4,280.66
Rentokil Initial (RTO) Director name: Mistry,Sarosh Amount purchased: 850 @ $5.43 Value: $3,805.96
Big Technologies (BIG) Director name: Morris,Daren John Amount purchased: 2,000 @ 178.00p Value: �3,560.00
Allianz Technology Trust (ATT) Director name: Patel,Neeta Amount purchased: 184 @ 268.38p Value: �493.82
(ITH) Director name: Myerson,Gilad Amount purchased: 96 @ 157.18p Value: �150.89
(ITH) Director name: Bruce,Alan Alexander Amount purchased: 96 @ 157.18p Value: �150.89
(ITH) Director name: Lewis,Iain Clifford Scobbie Amount purchased: 95 @ 157.18p Value: �149.32
Top Director Sells
Smith & Nephew (SN.) Director name: Nath,Deepak Amount sold: 1,771 @ 987.80p Value: �17,493.94
Smith & Nephew (SN.) Director name: Nath,Deepak Amount sold: 1,225 @ 987.80p Value: �12,100.55
Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 15,825 @ 27.05p Value: �4,280.66
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
